- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- February 2024
- 80 Pages
Europe
From €5752EUR$5,950USD£4,944GBP
- Report
- May 2023
- 236 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- May 2022
- 115 Pages
United States
From €4834EUR$5,000USD£4,155GBP
- Report
- September 2020
- 276 Pages
Global
From €5317EUR$5,500USD£4,570GBP
- Report
- December 2022
- 150 Pages
Global
From €5752EUR$5,950USD£4,944GBP
- Report
- August 2021
- 183 Pages
Global
From €3079EUR$3,185USD£2,646GBP
€4399EUR$4,550USD£3,781GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Webinar
- November 2019
- 90 Minutes
Global
The Laboratory Developed Test (LDT) market is a subset of the laboratory testing industry. It is composed of tests that are designed, manufactured, and used within a single laboratory. These tests are not subject to the same regulatory requirements as tests that are commercially available. LDTs are often used to diagnose rare diseases, detect genetic mutations, and monitor therapeutic response.
LDTs are typically used in clinical settings, such as hospitals and physician offices, and are often used to supplement or replace commercially available tests. They are also used in research settings to develop new tests and to validate existing tests.
The LDT market is highly competitive, with many companies offering a wide range of tests. Some of the major players in the market include Quest Diagnostics, LabCorp, ARUP Laboratories, Mayo Medical Laboratories, and Eurofins Scientific. Show Less Read more